Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers
Diabetes therapy : research, treatment and education of diabetes and related disorders（2022）
关键词
Fixed-ratio combination,iGlarLixi,Injection,Insulin glargine 100 U/ml,Questionnaire,SoloStar,Type 2 diabetes
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要